- It is important that Poland will present and promote its biotechnology sector at the most important biotech event in the region - says prof. Tadeusz Pietrucha, member of the National Development Council, an advisory body to the President of the Republic of Poland.
In adittion to Polish national stand, following polish companies representing biotech and pharma sectors will also take part in the event in Shanghai:
- Polpharma - the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. It actively operates in the markets of Central and Eastern Europe, the Caucasus and Central Asia. Company has 7 manufacturing plants in Poland, Russia and Kazakhstan, and 7 research and development centres. Manufacturer of a wide range of prescription drugs and pharmaceuticals for in-patient care.
- Vetos-Farma - established in 1990 company specializes in four segments: veterinary medicine, dentistry and pharmacy and laboratory tests. It is currently in the process of registering about a dozen medicinal products (Visitor).
- Clinmark - as leading Polish CRO specializing in clinical research in CEE and global clinical consulting Clinmark is committed to providing support for pharmaceutical and biotechnological companies in the area of research and development through operational activities, professional auditing, consulting and education (Visitor).
During the event, a press briefing will be organized at the Polish stand aiming to present Polish biotech and pharma industries to local media and business representatives.
CPhI China will be held on June 20-22, 2018 in Shanghai (Shanghai New International Expo Center).